期刊文献+

高龄院内获得性肺炎病原学分布及药敏分析 被引量:1

Pathogenic distribution and drug sensitivity analysis in very old patients with hospital-acquired pneumonia
下载PDF
导出
摘要 目的探讨高龄老年院内获得性肺炎(HAP)患者的危险因素和病原学分布特点及药敏分析。方法选择2006年1月-2012年4月解放军第161医院干部病房收治的老年HAP患者206例,回顾性分析其临床资料及痰培养结果。采用K—B法进行细菌药敏试验。按CLSI2009版判断结果。结果所有患者均存在基础疾病及多种高危因素,2011年1月1日-2012年4月25日共分离出215株致病菌,其中革兰阴性杆菌占61.55%,革兰阳性菌占26.63%,真菌占2.43%。大部分革兰阴性菌对亚胺培南、美罗培南敏感,革兰阳性球菌对利奈唑胺敏感。结论对于高龄HAP患者应积极控制危险因素,重视病原学检查,根据药敏结果针对性治疗,有助于达到较好的治疗效果,减少耐药菌株产生。 Objective To discuss the risk factors and pathogenic distribution of hospital-acquired pneumonia(HAP) in elderly patients and to perform the drug sensitivity analysis. Methods A total of 206 HAP patients were included from January 2006 to April 2012 in Chinese PLA 161st Hospital. Their clinical data and sputum culture results were analyzed retrospectively. Susceptibility test was carried out by Kirby-Bauer method according to CLSI2009. Results All 206 subjects suffered from multiple basic diseases and presented with many risk factors. Totally 215 strains were isolated, including gram negative bacteria(61.55%), gram positive cocci(26.63%) and Fungi(2.43%), respectively. Most bacilli were susceptible to imipenem and meropenem, and gram positive cocci to vancomycin and linezolid. Conclusions For elderly HAP patients, control of risk factors, detection of pathogens and use of antibiotics according to drug susceptibility will help to acquire satisfactory therapeutic effect and reduce the drug resistant strains.
出处 《中华老年多器官疾病杂志》 2012年第6期445-447,共3页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 老年人 80以上 医院获得性 肺炎 细菌性 危险因素 病原学分布 耐药性 elderly hospital acquired pneumonia, bacterial risk factors distribution of pathogens drug resistance
  • 相关文献

参考文献8

二级参考文献17

  • 1卢德友.1784例老年人肺结核临床特点分析[J].中华老年医学杂志,2005,24(7):530-531. 被引量:15
  • 2叶应妩,王毓三,主编.全国临床经验操作规程[M].第2版.南京:东南大学出版社,500-514.
  • 3Clinical and Laboratory Standards Institute(CLSI). Performance Standards for Antimicrobial susceptibility testing[S]. 2007.
  • 4Rodriguez-Bano J, Paterson DL. A change in the epidemicology of infections due to exterded spectrum β-lactamase producing organisms[J]. Clin Infect Dis, 2006,42(7) :935-937.
  • 5Paterson DL. The epidemiological profile of infections with multidrug resistant Preudomonas aeruginosa and Acinetobacter species[J]. Clin Infect Dis ,2006, 43(suppl 2):S43-S48.
  • 6Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa[J].Clin Infect Dis, 2006, 43(suppl 2):S49-S56.
  • 7Zavascki AP, Goldani LZ, Li J, et al. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review[J].J Anitmicrob Chemother, 2007, 60(6) : 1206-1215.
  • 8Li J, Nation RL, Turnidge JD, et al. Colistin:the re-emerging antibiotic for multidrug-resistant Gram-regative bacterial infections[J]. Lancet Infect Dis, 2006, 6(9) : 589-601.
  • 9Rahal JJ. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species[J]. Clin Infect Dis, 2006, 43 ( suppl 2) : S95- S99.
  • 10汪复.2006年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2008,8(1):1-9. 被引量:281

共引文献2573

同被引文献7

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部